Essex Woodlands Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-201,818
| Closed | -$58.7M | – | 9 |
|
|
2018
Q1 | $58.7M | Sell |
201,818
-445,000
| -69% | -$129M | 12.85% | 4 |
|
|
2017
Q4 | $121M | Sell |
646,818
-300,000
| -32% | -$56.2M | 21.91% | 2 |
|
|
2017
Q3 | $160M | Sell |
946,818
-503,182
| -35% | -$84.8M | 28.32% | 1 |
|
|
2017
Q2 | $208M | Hold |
1,450,000
| – | – | 37.57% | 1 |
|
|
2017
Q1 | $182M | Hold |
1,450,000
| – | – | 41.42% | 1 |
|
|
2016
Q4 | $163M | Hold |
1,450,000
| – | – | 37.26% | 1 |
|
|
2016
Q3 | $186M | Hold |
1,450,000
| – | – | 38.79% | 1 |
|
|
2016
Q2 | $158M | Hold |
1,450,000
| – | – | 39.93% | 1 |
|
|
2016
Q1 | $137M | Sell |
1,450,000
-700,000
| -33% | -$66.4M | 35.98% | 1 |
|
|
2015
Q4 | $194M | Hold |
2,150,000
| – | – | 35.5% | 1 |
|
|
2015
Q3 | $199M | Hold |
2,150,000
| – | – | 36.46% | 1 |
|
|
2015
Q2 | $141M | Sell |
2,150,000
-1,000,000
| -32% | -$65.7M | 25.51% | 2 |
|
|
2015
Q1 | $225M | Hold |
3,150,000
| – | – | 44.73% | 1 |
|
|
2014
Q4 | $120M | Hold |
3,150,000
| – | – | 37.42% | 1 |
|
|
2014
Q3 | $78.2M | Hold |
3,150,000
| – | – | 28.48% | 2 |
|
|
2014
Q2 | $79.2M | Hold |
3,150,000
| – | – | 16.47% | 3 |
|
|
2014
Q1 | $82M | Hold |
3,150,000
| – | – | 20.88% | 3 |
|
|
2013
Q4 | $84.2M | Hold |
3,150,000
| – | – | 42.34% | 1 |
|
|
2013
Q3 | $60M | Hold |
3,150,000
| – | – | 39.64% | 1 |
|
|
2013
Q2 | $67.9M | Buy |
+3,150,000
| New | +$67.9M | 52.05% | 1 |
|